RGD-modified pH-sensitive liposomes for docetaxel tumor targeting
Authors:
- 1 May 2015
- journal article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 129, 175-182
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21203112)
- Natural Science Foundation of Shandong Province (ZR2012BQ002)
This publication has 28 references indexed in Scilit:
- Synthesis, characterization and antitumor evaluation of CMCS–DTX conjugates as novel delivery platform for docetaxelInternational Journal of Pharmaceutics, 2013
- The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancerBiomaterials, 2012
- Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cellsInternational Journal of Pharmaceutics, 2011
- Antibody derivatization and conjugation strategies: Application in preparation of stealth immunoliposome to target chemotherapeutics to tumorJournal of Controlled Release, 2011
- Folate-Targeted Therapies for CancerJournal of Medicinal Chemistry, 2010
- Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animalsJournal of Controlled Release, 2010
- Docetaxel-related side effects and their managementEuropean Journal of Oncology Nursing, 2009
- Docetaxel for treatment of solid tumours: a systematic review of clinical dataThe Lancet Oncology, 2005
- Recent advances with liposomes as pharmaceutical carriersNature Reviews Drug Discovery, 2005
- Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseasesChemical Engineering Science, 2003